[go: up one dir, main page]

MX2007010349A - Composiciones y metodos para clasificar muestras biologicas. - Google Patents

Composiciones y metodos para clasificar muestras biologicas.

Info

Publication number
MX2007010349A
MX2007010349A MX2007010349A MX2007010349A MX2007010349A MX 2007010349 A MX2007010349 A MX 2007010349A MX 2007010349 A MX2007010349 A MX 2007010349A MX 2007010349 A MX2007010349 A MX 2007010349A MX 2007010349 A MX2007010349 A MX 2007010349A
Authority
MX
Mexico
Prior art keywords
compositions
methods
biological samples
classifying biological
classifying
Prior art date
Application number
MX2007010349A
Other languages
English (en)
Inventor
Toomas Neuman
Mehis Pold
Original Assignee
Cemines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cemines Inc filed Critical Cemines Inc
Publication of MX2007010349A publication Critical patent/MX2007010349A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invencion es concerniente con auto-anticuerpos y la deteccion de los mismos con epitopos de peptido. La invencion tambien es concerniente con patrones de auto-anticuerpo y su correlacion con distinciones de clase biologica.
MX2007010349A 2005-02-24 2006-02-24 Composiciones y metodos para clasificar muestras biologicas. MX2007010349A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65685905P 2005-02-24 2005-02-24
PCT/US2006/006431 WO2006091734A2 (en) 2005-02-24 2006-02-24 Compositions and methods for classifying biological samples

Publications (1)

Publication Number Publication Date
MX2007010349A true MX2007010349A (es) 2008-04-09

Family

ID=36928007

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007010349A MX2007010349A (es) 2005-02-24 2006-02-24 Composiciones y metodos para clasificar muestras biologicas.

Country Status (11)

Country Link
US (1) US20090075832A1 (es)
EP (1) EP1859266A4 (es)
JP (1) JP2008532014A (es)
KR (1) KR20080003321A (es)
CN (1) CN101160524A (es)
AU (1) AU2006216683A1 (es)
CA (1) CA2598889A1 (es)
IL (1) IL185458A0 (es)
MX (1) MX2007010349A (es)
RU (1) RU2007135030A (es)
WO (1) WO2006091734A2 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842480B2 (en) 2001-05-18 2010-11-30 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
CA2655933C (en) * 2006-06-23 2014-09-09 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
WO2008053573A1 (fr) 2006-10-30 2008-05-08 National University Corporation Hokkaido University Remède pour néoplasme malin
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
WO2009029716A1 (en) * 2007-08-28 2009-03-05 Ramot At Tel Aviv University Peptides inducing a cd4i conformation in hiv gp120 while retaining vacant cd4 binding site
TWI466680B (zh) * 2008-08-01 2015-01-01 Oncotherapy Science Inc Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN104829714A (zh) 2008-11-03 2015-08-12 阿莱斯亚生物疗法股份有限公司 特异性地阻滞肿瘤抗原的生物活性的抗体
GB0823366D0 (en) 2008-12-22 2009-01-28 Uni I Oslo Synthesis
KR101067815B1 (ko) * 2009-02-05 2011-09-27 서울대학교산학협력단 제1형 당뇨병의 신규한 진단 마커
JP5823964B2 (ja) 2009-08-14 2015-11-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 自閉症を診断及び治療する方法
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
TWI485245B (zh) * 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
MX352373B (es) 2011-03-31 2017-11-22 Adc Therapeutics Sa Anticuerpos contra antigeno 1 asociado con riñon y sus fragmentos de union de antigeno.
EP2745115B1 (de) * 2011-08-19 2016-05-18 Protagen AG Neues verfahren zur diagnostik von hochaffinen bindern und markersequenzen
WO2013031757A1 (ja) * 2011-08-29 2013-03-07 東レ株式会社 膵癌、乳癌、肺癌又は前立腺癌の検出用マーカー及び検査方法
IN2014CN04690A (es) 2012-01-09 2015-09-18 Alethia Biotherapeutics Inc
US20130183242A1 (en) * 2012-01-18 2013-07-18 University Of Connecticut Methods for identifying tumor-specific polypeptides
GB201319446D0 (en) 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
WO2015172843A1 (en) 2014-05-16 2015-11-19 Biontech Diagnostics Gmbh Methods and kits for the diagnosis of cancer
US20150335679A1 (en) * 2014-05-20 2015-11-26 Kiromic, Llc Methods and Compositions for Treating Malignancies with Dendritic Cells
US10526397B2 (en) 2015-01-21 2020-01-07 Inhibrx, Inc. Non-immunogenic single domain antibodies
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
JP6873060B2 (ja) 2015-06-26 2021-05-19 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ 自閉症を診断および治療するための抗原性ペプチドおよびその使用
RU2021111382A (ru) 2015-07-16 2021-05-21 Инхибркс, Инк. Мультивалентные и мультиспецифические гибридные белки, связывающиеся с dr5
HK1258386A1 (zh) 2015-10-05 2019-11-08 Immatics Biotechnologies Gmbh 用於小细胞肺癌和其他癌症免疫治疗的肽和肽组合物
EP3193173A1 (en) * 2016-01-14 2017-07-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Serological autoantibodies as biomarker for colorectal cancer
GB201604458D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
CA3048108A1 (en) * 2017-01-27 2018-08-02 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
CN108948184B (zh) * 2017-05-22 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别衍生自prame抗原短肽的t细胞受体
CN109400697B (zh) * 2017-08-17 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别prame抗原短肽的tcr及其相关组合物
EP3756680A1 (en) * 2019-06-26 2020-12-30 Universitat de Lleida Intermediate filament-derived peptides and their uses
EP3999525A4 (en) * 2019-07-15 2023-08-09 Geisinger Health System COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST CANCER WITH A NOVEL CAPER ALPHA MLL1 COMPLEX
CN110922492B (zh) * 2019-12-18 2022-02-15 重庆医科大学 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法
CN111337678B (zh) * 2020-02-21 2023-06-06 杭州凯保罗生物科技有限公司 与肿瘤免疫治疗效果相关的生物标志物及其应用
CN116773798A (zh) * 2023-06-16 2023-09-19 北京三品医疗科技有限公司 多肽的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
EP1337667A2 (en) * 2000-11-16 2003-08-27 Cedars-Sinai Medical Center Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
WO2002073209A2 (de) * 2001-03-10 2002-09-19 Affina Immuntechnik Gmbh Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
JP4594588B2 (ja) * 2001-04-10 2010-12-08 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ 抗体特異的プロファイルの治療的および診断的使用方法
WO2003042357A2 (en) * 2001-09-28 2003-05-22 Incyte Genomics, Inc. Enzymes
EP1578970A1 (de) * 2002-12-23 2005-09-28 Hans-Jürgen Thiesen Human-autoantigene und deren verwendung
CA2511816A1 (en) * 2002-12-26 2004-07-22 Cemines, Inc. Methods and compositions for the diagnosis, prognosis, and treatment of cancer

Also Published As

Publication number Publication date
EP1859266A4 (en) 2010-07-28
JP2008532014A (ja) 2008-08-14
IL185458A0 (en) 2008-01-06
RU2007135030A (ru) 2009-03-27
AU2006216683A1 (en) 2006-08-31
US20090075832A1 (en) 2009-03-19
WO2006091734A3 (en) 2007-02-08
KR20080003321A (ko) 2008-01-07
CA2598889A1 (en) 2006-08-31
EP1859266A2 (en) 2007-11-28
WO2006091734A2 (en) 2006-08-31
WO2006091734A9 (en) 2006-10-19
CN101160524A (zh) 2008-04-09

Similar Documents

Publication Publication Date Title
MX2007010349A (es) Composiciones y metodos para clasificar muestras biologicas.
WO2007136893A3 (en) Anti-fgf19 antibodies and methods using same
WO2011047087A3 (en) Protein detection via nanoreporters
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
CU24058B1 (es) Antagonistas de pcsk9
IL202322A0 (en) Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies
EA201100300A1 (ru) Композиции и способы, предназначенные для направленного воздействия антител на белок c5 системы комплемента
IL202598A0 (en) High sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest
EP2333116A3 (en) Markers of renal transplant rejection and renal damage
IL187867A0 (en) Biomarker for ovarian cancer: ctap3-related proteins
DK2211180T3 (da) Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer
CR11504A (es) Deteccion mejorada de la expresion de mage-a
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
EA201500316A1 (ru) Антагонисты толл-подобного рецептора 3
WO2011053565A3 (en) Compositions and methods for detecting a tauopathy
WO2011159928A3 (en) Anti-dr4 agonist antibodies
PL1987357T3 (pl) Polipeptydy rozpoznawane przez przeciwciała anty-Trichinella oraz ich zastosowanie
BRPI0607323A2 (pt) composições e uso de polipeptìdeos e kits para a detecção de anticorpo que se liga especificamente a um polipeptìdeo
WO2009120183A3 (en) System for the detection of a biological pathogen and use thereof
WO2009082445A3 (en) Novel devices for the detection of the presence and/or activity of proteases in biological samples
ATE476655T1 (de) Doxorubicin-immuntest
EP2386633A4 (en) NEW TUMORANT EEF2
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme
WO2007001962A3 (en) Systems and methods for generating biological material

Legal Events

Date Code Title Description
FA Abandonment or withdrawal